These data suggest that inhibition of KDM4B promotes cGAS methylation and subsequent inactivation in Trex1−/− mice, which could potentially block the overactivation of cGAS–STING signaling and benefit autoimmune disease management. Here, TREX1 is linked to autoimmune disease.